Featured Research

from universities, journals, and other organizations

Preventive Removal Of Both Breasts Reduces Chance Of Breast Cancer In Women At Elevated Risk

Date:
March 24, 2005
Source:
Harvard University
Summary:
Women with a moderately elevated risk of breast cancer who underwent surgery to have both breasts removed reduced their risk of getting the disease by about 95 percent, a recent study concludes. The study, conducted by scientists at six health plans, is published in the March 14 issue of the Archives of Internal Medicine.

Women with a moderately elevated risk of breast cancer who underwent surgery to have both breasts removed reduced their risk of getting the disease by about 95 percent, a recent study concludes. The study, conducted by scientists at six health plans, is published in the March 14 issue of the Archives of Internal Medicine.

"Prophylactic mastectomy appears very effective in preventing breast cancer, but choosing this procedure is a complex decision," said Ann M. Geiger, lead author of the study. "Prophylactic mastectomy prevents breast cancer but also carries a risk of complications and may impact a woman's psychosocial health. We suggest a woman considering the procedure talk to her doctor, family, and friends, and get genetic counseling to help her understand her risk of breast cancer and learn about all her options. In addition to prophylactic mastectomy, women may choose to manage their risk with tamoxifen, prophylactic oophorectomy, regular mammograms, and possibly MRI."

The study's patients were female members of multiple health plans who were 18 to 80 years of age between Jan. 1, 1979, and Dec. 31, 1998, and who had at least one breast cancer risk factor. The most often noted factors were having a family history of breast cancer, a personal history of atypical hyperplasia (a potentially pre-cancerous condition), and one or more benign breast biopsies.


Story Source:

The above story is based on materials provided by Harvard University. Note: Materials may be edited for content and length.


Cite This Page:

Harvard University. "Preventive Removal Of Both Breasts Reduces Chance Of Breast Cancer In Women At Elevated Risk." ScienceDaily. ScienceDaily, 24 March 2005. <www.sciencedaily.com/releases/2005/03/050323134132.htm>.
Harvard University. (2005, March 24). Preventive Removal Of Both Breasts Reduces Chance Of Breast Cancer In Women At Elevated Risk. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/03/050323134132.htm
Harvard University. "Preventive Removal Of Both Breasts Reduces Chance Of Breast Cancer In Women At Elevated Risk." ScienceDaily. www.sciencedaily.com/releases/2005/03/050323134132.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins